Dr. Jaidev Rajpal appointed MD & CEO of Jubilant Generics
He has over two decades of rich experience in management consulting, advising and transforming leading generic pharmaceutical companies in India and global markets
He has over two decades of rich experience in management consulting, advising and transforming leading generic pharmaceutical companies in India and global markets
Carbamazepine Tablets are indicated for use as an anticonvulsant drug and in the treatment of the pain associated with true trigeminal neuralgia
The company was directed to submit a plan of compliance by July 15, 2022
Upgrades and global expansion provide additional control, visibility, reliability and recovery for patient-critical, time-and temperature-sensitive products
Steinberg brings nearly three decades of experience in biopharmaceutical equity research to Prolacta's executive team.
he Phase 2 TIDAL data generated to date continue to highlight zandelisib's therapeutic profile and the potential to benefit patients
Under the agreement, Lonza will deliver cGMP-standard drug substance for clinical supply
Nearly 1 million people are living with multiple sclerosis in the United States. Spasticity is a commonly reported symptom for MS, with an estimated prevalence of spasticity of 67%
As part of Daiichi Sankyo’s 2030 vision, it plans to strengthen its oncology portfolio
The product will be commercialized from Unichem's Ghaziabad plant
Subscribe To Our Newsletter & Stay Updated